RENAL-Male GU Flashcards
Pain Male GU
severe
Urinary tract obstruction
Inflammation -parenchyma of a GU organ
Pyelonephritis
Prostatitis
Epididymitis
Discomfort
Cystitis
Urethritis
GI- n/v/d, illeus
Tumor-painless
BUT…pain if obstruction or extends
Renal Pain
Ipsilateral CVA- lateral to the sacrospinalis muscle and beneath 12th rib
D/t-Acute distention of the renal capsule
DDX- irritation of the costal nerves, most commonly T10–T12
Not colicky/intermittent
Bladder Pain
overdistension
inlfammed
Prostatic Pain
Inflammation distention capsule Poorly localized Lower abdominal Inguinal Perineal Lumbosacral Rectal pain Irritative urinary sx Acute urinary retention
Penile Pain
Erecion d/t
Peyronie’s disease
priapism
Flaccid
inflammation bladder
urethra
Paraphimosis - cicumcised
Testicular Pain
Acute
Epididymitis
Torsion testicle
Chronic scrotal pain
Hydrocele, Varicocele
Dull, heavy, not radiate
Referred pain to kidneys or retroperitoneum
Lower Urinary Tract Symptoms
Irritative Symptoms: Urinary frequency Nocturia Dysuria Incontinence Stress Urge
Obstructive Symptoms: Decreased force hesitancy Intermittency/colic Post void dribbling Straining
Infections
Urethral Discharge
Fever and Chills:
Pyelonephritis
Prostatitis
Epididymitis (acute)
PMH risk
Systemic diseases: Diabetes Mellitus Multiple Sclerosis TB Schistosomiasis
Family history
Prostate cancer
Stones (cystine)
Renal tumors (some types)
Surgical History
Cigarette smoking
bladder cancer
Erectile dysfunction
Chronic alcoholism
Impaired urinary fx
Sexual dysfunction
Testicular atrophy
Physical Examination
General Observations Cachexia -Malignancy, TB Jaundice or pallor Gynecomastia Endocrinologic dz Alcoholism Hormonal therapy
Kidney mass
Bladder- percuss MC
Bimanual-anestheia ideal
Penius-
hypospadius-ventral side (below glans spot)
epispadius-dorsal (above glans
Physical Examination- inferior
Scrotum and Contents
Painful:
Torsion
Epididymitis
Painless
Spermatocele
Hydrocele
Varicocele
Transillumination
Cystic (ligts up) vs solid
***Painless solid testicular mass is tumor until proven otherwise
Rectal and Prostate
Digital rectal examination (DRE):
Every male after age 50 years (controversial)
Men who present for urologic evaluation
BPH epidem
40-50% men aged 51-60 years
>80% men >80 years
Considerable disability
Low rate of mortality
Size/volume- prostate inc. w/ age and tone, Urinary flow dec.
Post void residual inc. d/t pressure on the urethra from prostate
Develops in the periurethral or transitional zone
Diagnosis of BPH
Frequency nocturia hesitancy urgency weak stream (LUTS) Sx progress gradually
Rule out UTI/Prostatitis, urethral stricture, bladder or prostate cancer, bladder calculi, neurogenic bladder
Normal- smooth rubbery, firm, symmetrical
Evaluation for BPH
GU
DRE: Size, consistency, nodules (bladder), induration (infxn), symmetry
Neurologic exam- sphincter tone
UA-UTI/prostatitis- hematuria
Serum creatinine, blood glucose-Bladder outlet obstruction, renal/pre-renal dz, DM
Serum Prostate Specific Antigen (PSA)* >4.0 ng/mL prostate cancer
Total serum PSA, %free PSA ration:
% free PSA
LOW= prostate cancer,
HIGH= BPH
(Urology):Maximal urinary flow rate
<15 mL/sec indicates obstruction
Post void residual urine volume
>12 mL abnormal in men
Treatment of BPH MILD-SEVERE
MILD 0-7 AUA
Monitor
Treat symptoms
Prevention - behavior modification- no fluids past 7pm, avoid diuretics meds/food
Herbal-Saw palmetto (EU) plant extract, controversial
No- FDA, No standards
Severe >20
Transurethral resection of the prostate (TURP)
Standard
TX OF BPH MOD
Moderate BPH-combo no EVB, long therapy
DOC 1st- **α-1-adrenergic antagonists (terazosin, doxazosin)
helps outlet obstruction d/t tension of prostatic smooth muscle
NO change in volume
SE-orthostatic hypotension, start low 1-6wks titrate to TD
5-α-reductase inhibitors-(finasteride, dutasteride)
NO ED
Inhibit conversion of testosterone to dihydrotestosterone
Reduce size of the prostate
Side effects: decreased libido, erectile dysfxn
Decrease in serum PSA levels-
Phosphodiesterase (PDE-5) inhibitors
BPH with ED
Tadalafil (Cialis) approved by FDA for this purpose
also dec BP- Inc hypotensive effects of α-blockers